156 related articles for article (PubMed ID: 12687561)
1. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
Jover JA; Hernández-Garcia C; Morado IC; Vargas E; Bañares A; Fernandez-Gutierrez B
Arthritis Rheum; 2003 Apr; 48(4):1158-9. PubMed ID: 12687561
[No Abstract] [Full Text] [Related]
2. Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
Spiera RF; Kupersmith M; Paget S; Spiera H
Arthritis Rheum; 2003 Apr; 48(4):1159-60; author reply 1160-1. PubMed ID: 12687562
[No Abstract] [Full Text] [Related]
3. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
[TBL] [Abstract][Full Text] [Related]
4. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
5. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
[TBL] [Abstract][Full Text] [Related]
6. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
7. Giant cell arteritis--the methotrexate debate revisited.
Rimar D; Rozenbaum M; Zisman D; Boulman N; Slobodin G; Eder L; Feld J; Rosner I
J Rheumatol; 2006 Jul; 33(7):1458-9. PubMed ID: 16862661
[No Abstract] [Full Text] [Related]
8. Improving therapeutic options for patients with giant cell arteritis.
Pipitone N; Salvarani C
Curr Opin Rheumatol; 2008 Jan; 20(1):17-22. PubMed ID: 18281852
[TBL] [Abstract][Full Text] [Related]
9. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
Bertoli AM; Font YM; Nadal A; Vilá LM
Arthritis Rheum; 2007 May; 56(5):1723; author reply 1723-4. PubMed ID: 17469171
[No Abstract] [Full Text] [Related]
10. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
[TBL] [Abstract][Full Text] [Related]
11. Development of autoimmune diseases after vaccination.
Pou MA; Diaz-Torne C; Vidal S; Corchero C; Narvaez J; Nolla JM; Diaz-Lopez C
J Clin Rheumatol; 2008 Aug; 14(4):243-4. PubMed ID: 18766128
[No Abstract] [Full Text] [Related]
12. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
[TBL] [Abstract][Full Text] [Related]
13. Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: comment on the article by Mazlumzadeh et al.
Arashvand K
Arthritis Rheum; 2007 May; 56(5):1722; author reply 1723-4. PubMed ID: 17469170
[No Abstract] [Full Text] [Related]
14. [Corticosteroid saving-up in giant cell arteritis?].
Schnabel A
Dtsch Med Wochenschr; 2002 Sep; 127(37):1910. PubMed ID: 12226792
[No Abstract] [Full Text] [Related]
15. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
Mahr AD; Jover JA; Spiera RF; Hernández-García C; Fernández-Gutiérrez B; Lavalley MP; Merkel PA
Arthritis Rheum; 2007 Aug; 56(8):2789-97. PubMed ID: 17665429
[TBL] [Abstract][Full Text] [Related]
16. Summaries for patients. Prednisone plus methotrexate for polymyalgia rheumatica.
Ann Intern Med; 2004 Oct; 141(7):I12. PubMed ID: 15466761
[No Abstract] [Full Text] [Related]
17. Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.
Airò P; Antonioli CM; Vianelli M; Toniati P
Rheumatology (Oxford); 2002 Mar; 41(3):347-9. PubMed ID: 11934977
[No Abstract] [Full Text] [Related]
18. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
[TBL] [Abstract][Full Text] [Related]
19. [Induction therapy with corticoid pulses for treatment of temporal arteritis].
Krüger K
Z Rheumatol; 2007 Mar; 66(2):165-6. PubMed ID: 17294060
[No Abstract] [Full Text] [Related]
20. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
